Sort   by:  
 Page size 
UnknownTERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
Not available
S-EPMC6193287 | biostudies-literature
UnknownIs there pseudoprogression in secondary glioblastomas?
Not available
S-EPMC4349215 | biostudies-literature
UnknownMolecular landscape and clinical correlates of olfactory groove meningiomas: a multi-institutional study.
Not available
S-EPMC12558015 | biostudies-literature
UnknownRadiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.
Not available
S-EPMC6924170 | biostudies-literature
UnknownManaging hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis.
Not available
S-EPMC12375857 | biostudies-literature
UnknownComprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase-mutant lower-grade gliomas.
Not available
S-EPMC11822795 | biostudies-literature
UnknownLoss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.
Not available
S-EPMC12657538 | biostudies-literature
UnknownPI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors.
Not available
S-EPMC6924174 | biostudies-literature
UnknownGenotype-targeted local therapy of glioma.
Not available
S-EPMC6130372 | biostudies-literature
UnknownThe concept, intention, and evaluation of the term treatment-refractory meningioma.
Not available
S-EPMC12420741 | biostudies-literature
Sort   by:  
 Page size